Semaglutide promotes bone marrow–derived progenitor cell flux towards an anti-inflammatory and pro-regenerative profile in high-risk patients: the SEMA-VR CardioLink-15 trialBrady Park, Subodh Verma, Ehab Bakbak et al.|European Heart Journal|2025Cited by 8
TREATMENT IMPLICATIONS OF THE REDUCE-IT RESULTS TO PEOPLE OF SOUTH ASIAN (SA) DESCENT LIVING IN CANADA WITH KNOWN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE(THE REDUCE-IT CANADA SA STUDY)A. Krishnaraj, Sumit Verma, Ehab Bakbak et al.|Canadian Journal of Cardiology|2022Cited by 0